CLAL INSURANCE ENTERPRISES HOLDINGS LTD. (CLIS)
Financial Report for Q1 2026- translated version
Financial Report for Q1 2026- translated version
Keysight Joins Siemens Digital Industries Software Solution Partner Program as a Software and Technology Partner
CARNIVAL CORPORATION LTD. TO HOLD CONFERENCE CALL ON SECOND QUARTER EARNINGS
Change in holdings of interested parties/officers
Old National Bank Awarded Bauer Financial 5-Star Superior Rating for Financial Strength and Stability
Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients
Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients
Xcel Brands Announces License Agreement for Trust. Respect. Love by Cesar Millan with EcoStrong
POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm
SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the Schall Law Firm